Effects of Different Weight Loss Approaches on CVD Risk
Purpose of Review
In this review, we aimed to answer the question as to whether deliberate weight loss can reduce cardiovascular events or improve cardiovascular risk factors and whether different methods of weight loss can have a differential effect on risk factor improvement.
It would appear that deliberate weight loss reduces total mortality by 16% in obese people with risk factors including type 2 diabetes. People with type 2 diabetes who lose at least 10% of their initial body weight reduce CVD end points by 21% with dietary weight loss while the effect is greater with the greater weight loss induced by bariatric surgery with a 32% reduction in events. Mortality reduction may vary from 29 to up to 79%. Replacing some carbohydrate with protein appears to enhance weight maintenance over 12 months and in addition lowers serum triglyceride and blood pressure. A very-low-carbohydrate diet elevates LDL cholesterol when a high saturated fat “Atkins” style approach is used, but a high unsaturated fat version is safe and effective over a 12-month period and reduces medication requirements in people with type 2 diabetes. A very-low-calorie liquid diet produces excellent weight loss in the short-term, but long-term weight loss is no different to less restrictive dieting.
Weight loss lowers CVD events and total mortality and a higher protein (18–25% of energy), lower carbohydrate (< 45% of energy) diet may be superior for weight maintenance and risk factor improvement, but there are no data on event reduction.
KeywordsCardiovascular disease Total mortality Bariatric surgery Dietary weight loss Protein Carbohydrate
Compliance with Ethical Standards
Conflict of Interest
Peter Clifton and Jennifer Keogh declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 4.•• Sheng B, Truong K, Spitler H, Zhang L, Tong X, Chen L. The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis. Obes Surg. 2017. Doi: https://doi.org/10.1007/s11695-017-2866-4. Clear benefits of bariatric surgery on mortality.
- 9.•• Look ARG, Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4(11):913–21. https://doi.org/10.1016/s2213-8587(16)30162-0 . Dietary-induced weight loss lowers CVD events in type 2 diabetes.
- 10.•• Baum A, Scarpa J, Bruzelius E, Tamler R, Basu S, Faghmous J. Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial. Lancet Diabetes Endocrinol. 2017;5(10):808–15. https://doi.org/10.1016/S2213-8587(17)30176-6. Volunteers in poor health do badly with weight loss. CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Look ARG, Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566–75.Google Scholar
- 12.Pedersen LR, Olsen RH, Anholm C, Walzem RL, Fenger M, Eugen-Olsen J, et al. Weight loss is superior to exercise in improving the atherogenic lipid profile in a sedentary, overweight population with stable coronary artery disease: a randomized trial. Atherosclerosis. 2016;246:221–8.CrossRefPubMedGoogle Scholar
- 14.Nissen SE, Nicholls SJ, Wolski K, Rodes-Cabau J, Cannon CP, Deanfield JE, et al. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA. 2008;299(13):1547–60.CrossRefPubMedGoogle Scholar
- 18.Tall AR. Rader DJ. Circ Res: The Trials and Tribulations of CETP Inhibitors; 2017.Google Scholar
- 19.Linsel-Nitschke P, Gotz A, Erdmann J, Braenne I, Braund P, Hengstenberg C, et al. Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease—a Mendelian randomisation study. PLoS One. 2008;3(8):e2986.CrossRefPubMedPubMedCentralGoogle Scholar
- 22.• Maki KC, Guyton JR, Orringer CE, Hamilton-Craig I, Alexander DD, Davidson MH. Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia. J Clin Lipidol. 2016;10(4):905–14. https://doi.org/10.1016/j.jacl.2016.03.008. Weight loss may be providing benefit by TG lowering. CrossRefPubMedGoogle Scholar
- 24.•• Xu L, Borges MC, Hemani G, Lawlor DA. The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study. Diabetologia. 2017; https://doi.org/10.1007/s00125-017-4396-y. The effect of BMI is mostly mediated through TG levels.
- 25.Stelmach-Mardas M, Walkowiak J. Dietary interventions and changes in cardio-metabolic parameters in metabolically healthy obese subjects: a systematic review with meta-analysis. Nutrients. 2016;8(8).Google Scholar
- 27.Headland M, Clifton PM, Carter S, Keogh JB. Weight-loss outcomes: a systematic review and meta-analysis of intermittent energy restriction trials lasting a minimum of 6 months. Nutrients. 2016;8(6).Google Scholar
- 28.• Davis CS, Clarke RE, Coulter SN, Rounsefell KN, Walker RE, Rauch CE, et al. Intermittent energy restriction and weight loss: a systematic review. Eur J Clin Nutr. 2016;70(3):292–9. https://doi.org/10.1038/ejcn.2015.195. No special benefit from intermittent energy restriction. CrossRefPubMedGoogle Scholar
- 31.Byrne NM, Sainsbury A, King NA, Hills AP, Wood RE. Intermittent energy restriction improves weight loss efficiency in obese men: the MATADOR study. Int J Obes 2017.Google Scholar
- 32.Conley M, Le Fevre L, Haywood C, Proietto J. Is two days of intermittent energy restriction per week a feasible weight loss approach in obese males? A randomised pilot study. Nutr Diet. 2017.Google Scholar
- 33.Alhamdan BA, Garcia-Alvarez A, Alzahrnai AH, Karanxha J, Stretchberry DR, Contrera KJ, et al. Alternate-day versus daily energy restriction diets: which is more effective for weight loss? A systematic review and meta-analysis. Obes Sci Pract. 2016;2(3):293–302.CrossRefPubMedPubMedCentralGoogle Scholar
- 35.Trepanowski JF, Kroeger CM, Barnosky A, Klempel MC, Bhutani S, Hoddy KK, et al. Effect of alternate-day fasting on weight loss, weight maintenance, and cardioprotection among metabolically healthy obese adults: a randomized clinical trial. JAMA Intern Med. 2017;177(7):930–8.CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003;41(10):1769–75.CrossRefPubMedGoogle Scholar
- 39.• Joris PJ, Zeegers MP, Mensink RP. Weight loss improves fasting flow-mediated vasodilation in adults: a meta-analysis of intervention studies. Atherosclerosis. 2015;239(1):21–30. https://doi.org/10.1016/j.atherosclerosis.2014.12.056. Weight loss improves FMD which is a good marker of CVD risk. CrossRefPubMedGoogle Scholar
- 44.Metzner CE, Folberth-Vogele A, Bitterlich N, Lemperle M, Schafer S, Alteheld B, et al. Effect of a conventional energy-restricted modified diet with or without meal replacement on weight loss and cardiometabolic risk profile in overweight women. Nutr Metab (Lond). 2011;8(1):64.CrossRefGoogle Scholar
- 48.Wycherley TP, Moran LJ, Clifton PM, Noakes M, Brinkworth GD, et al. Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials.Google Scholar
- 55.• Larsen TM, Dalskov SM, van Baak M, Jebb SA, Papadaki A, Pfeiffer AF, et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med. 2010;363(22):2102–13. https://doi.org/10.1056/NEJMoa1007137. High protein diets useful in weight maintenance. CrossRefPubMedPubMedCentralGoogle Scholar
- 57.Navas-Carretero S, Holst C, Saris WH, van Baak MA, Jebb SA, Kafatos A, et al. The impact of gender and protein intake on the success of weight maintenance and associated cardiovascular risk benefits, independent of the mode of food provision: the DiOGenes randomized trial. J Am Coll Nutr. 2016;35(1):20–30.CrossRefPubMedGoogle Scholar
- 65.• Tay J, Luscombe-Marsh ND, Thompson CH, Noakes M, Buckley JD, Wittert GA, et al. Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial. Am J Clin Nutr. 2015;102(4):780–90. https://doi.org/10.3945/ajcn.115.112581. Well controlled trial showing modest benefit oa very low carbohydrate diet on diabetes medication and glycemic variabality. CrossRefPubMedGoogle Scholar
- 66.Qian F, Korat AA, Malik V, Hu FB. Metabolic effects of monounsaturated fatty acid-enriched diets compared with carbohydrate or polyunsaturated fatty acid-enriched diets in patients with type 2 diabetes: a systematic review and Meta-analysis of randomized controlled trials. Diabetes Care. 2016;39(8):1448–57.CrossRefPubMedPubMedCentralGoogle Scholar
- 72.Hooper L, Abdelhamid A, Bunn D, Brown T, Summerbell CD, Skeaff CM. Effects of total fat intake on body weight. Cochrane Database Syst Rev. 2015;8:CD011834.Google Scholar
- 74.Juanola-Falgarona M, Salas-Salvado J, Ibarrola-Jurado N, Rabassa-Soler A, Diaz-Lopez A, Guasch-Ferre M, et al. Effect of the glycemic index of the diet on weight loss, modulation of satiety, inflammation, and other metabolic risk factors: a randomized controlled trial. Am J Clin Nutr. 2014;100(1):27–35.CrossRefPubMedGoogle Scholar
- 75.• Clar C, Al-Khudairy L, Loveman E, Kelly SA, Hartley L, Flowers N, et al. Low glycaemic index diets for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2017;7:CD004467. https://doi.org/10.1002/14651858.CD004467.pub3. No effect of glycemic index on CHD risk. PubMedCrossRefGoogle Scholar